|
|
Volumn 59, Issue 8, 2002, Pages 402-409
|
|
Insulin therapy in Type 2 diabetes
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HUMALOG MIX 25;
HUMINSULIN BASAL;
HUMINSULIN LILLY BASAL;
HUMINSULIN LILLY LONG;
HUMINSULIN LILLY NORMAL;
INSULATARD HM;
INSULIN ASPART;
INSULIN DERIVATIVE;
INSULIN LISPRO;
INSULIN ZINC SUSPENSION;
ISOPHANE INSULIN;
METFORMIN;
MIXTARD HM 30;
MONOCOMPONENT INSULIN;
NEUTRAL INSULIN;
ORAL ANTIDIABETIC AGENT;
RECOMBINANT HUMAN INSULIN;
SULFONYLUREA DERIVATIVE;
ULTRALONG;
UNCLASSIFIED DRUG;
ANTIDIABETIC AGENT;
INSULIN;
ARTICLE;
CONTROLLED STUDY;
DIABETES CONTROL;
DIET RESTRICTION;
DIET THERAPY;
DRUG CONTRAINDICATION;
DRUG FORMULATION;
DRUG SAFETY;
GENERAL PRACTICE;
GLUCOSE BLOOD LEVEL;
HUMAN;
INJECTION;
INSULIN TREATMENT;
MEAL;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PHYSICAL ACTIVITY;
TREATMENT FAILURE;
TREATMENT INDICATION;
DELAYED RELEASE FORMULATION;
DOSE RESPONSE;
DRUG ADMINISTRATION;
DRUG COMBINATION;
DELAYED-ACTION PREPARATIONS;
DIABETES MELLITUS, TYPE 2;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
DRUG THERAPY, COMBINATION;
HUMANS;
HYPOGLYCEMIC AGENTS;
INSULIN;
|
|
EID: 0036352177
PISSN: 00405930
EISSN: None
Source Type: Journal
DOI: 10.1024/0040-5930.59.8.402 Document Type: Article |
|
Times cited : (1)
|
|
References (8)
|
